Skip to content
healthcare.dev
Get a free key

KALI SULPH

NDC 54973-5230, potassium sulfate, tablet, from Hyland's Inc..

Product NDC
54973-5230
Status
Listed
Labeler
Hyland's Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/54973-5230 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM SULFATE6 [hp_X]/1

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]

Package NDCNDC-11Package
54973-5230-154973523001500 TABLET in 1 BOTTLE, PLASTIC (54973-5230-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 54973-5230 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/54973-5230 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 54973-5230. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.